XML 107 R97.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT INFORMATION - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Disaggregation of Revenue [Line Items]        
Revenues $ 2,238 $ 2,046 $ 6,349 $ 5,931
Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 999 935 2,768 2,647
Devices        
Disaggregation of Revenue [Line Items]        
Revenues 494 462 1,469 1,370
OTC        
Disaggregation of Revenue [Line Items]        
Revenues 457 405 1,313 1,183
Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 263 220 731 657
Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 25 24 68 74
Salix        
Disaggregation of Revenue [Line Items]        
Revenues 614 544 1,667 1,509
Salix | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 613 543 1,668 1,508
Salix | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 1 1 (1) 1
International        
Disaggregation of Revenue [Line Items]        
Revenues 275 250 781 727
International | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 63 68 178 192
International | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
International | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 47 39 125 112
International | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 151 131 438 385
International | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 14 12 40 38
Solta Medical        
Disaggregation of Revenue [Line Items]        
Revenues 83 72 244 201
Solta Medical | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 83 72 244 201
Solta Medical | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified        
Disaggregation of Revenue [Line Items]        
Revenues 259 238 684 722
Diversified | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 210 206 567 608
Diversified | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 2 2 6 5
Diversified | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 40 24 92 91
Diversified | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 7 6 19 18
Bausch + Lomb        
Disaggregation of Revenue [Line Items]        
Revenues 1,007 942 2,973 2,772
Bausch + Lomb | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 113 118 355 339
Bausch + Lomb | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 411 390 1,225 1,169
Bausch + Lomb | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 408 364 1,182 1,066
Bausch + Lomb | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 72 65 201 181
Bausch + Lomb | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues $ 3 $ 5 $ 10 $ 17